Jeffrey S. Hackman - 16 May 2025 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Chief Executive Officer, Director
Signature
/s/ Jeff Hackman
Issuer symbol
FENC
Transactions as of
16 May 2025
Net transactions value
+$104,602
Form type
4
Filing time
19 May 2025, 17:42:21 UTC
Previous filing
03 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hackman Jeffrey S. Chief Executive Officer, Director 68 TW ALEXANDER DRIVE, PO BOX 13628, RESEARCH TRIANGLE PARK /s/ Jeff Hackman 19 May 2025 0001926254

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Purchase $6,986 +1,035 $6.75 1,035 16 May 2025 Direct F1
transaction FENC Common Shares Purchase $97,615 +13,965 +1349% $6.99 15,000 19 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction Code P - Open market or private purchase of non-derivative or derivative security